10 research outputs found

    Study on Predisposing Factors and Control Measures against Cryptosporidiosis in Buffalo Calves at Cattle Colony Hyderabad, Sindh, Pakistan

    Get PDF
    The current study looked at the variables affecting the frequency of Cryptosporidium Parvum in buffalo calves at the Hyderabad Cattle Colony. From calves, 100 fecal samples were taken in total, preserved, and analyzed using direct smear and Ziehl-Neelsen staining methods. 74 percent of the samples tested positive for Cryptosporidium Parvum. Disease rates were higher in Nili Ravi calves (86 %) compared to Kundhi calves (62 %), with a statistically significant difference (

    Brucellosis and its Diagnostic Techniques in Animals: a Comprehensive Review

    Get PDF
    Brucellosis is a highly zoonotic infection found in animals and human, it has a high death ratio and lifetime sterility rate. The rates of intra- and interspecific infections have dramatically increased in recent years as a result of inadequate management and scarce resources particularly in developing nations. In cattle, reduced milk yield and elevated body temperature are the primary indicators, whereas in humans, soaring fever, overall malaise, and arthritis are the hallmarks of late-term abortion. Despite the fact that this diseases in animals and humans found unclear clinically, it will leads towards the hindrance in diagnosing this infectious illness serologically, PCR is an only way to diagnose this illness accurately. In developing nations, brucellosis poses a significant risk to livestock and public health because of its intricate nature. With an emphasis on developing nations specifically, we outlined the most recent research, noteworthy developments, and difficulties in the management and immunization against brucellosis in this review

    A Comprehensive Study on One Health Strategy and Public Health Effects of Salmonella

    Get PDF
    Salmonella poses a significant public health challenge due to its antibiotic resistance, zoonotic transmission, and diverse clinical manifestations. Over 60 % of human diseases are zoonotic, influenced by ecological dynamics and human activities such as land use changes, population growth, and international travel. Foodborne diseases, particularly those caused by Salmonella spp., have a substantial global impact, especially in low-income countries. Salmonella is divided into two species, Salmonella enterica and Salmonella bongori, with more than 2000 serotypes and six subspecies within S. enterica. This bacterium is highly adaptable, surviving extreme conditions such as drying, high salt concentrations, and acidic environments. Detection methods typically involve pre-enrichment, followed by specific enrichment, plating, and identification through serological and molecular techniques like PCR. Severe cases, especially in vulnerable populations, often require antimicrobial treatment. Salmonella’s pathogenicity is driven by its ability to invade, persist, and replicate within host cells, facilitated by Salmonella pathogenicity islands (SPIs) and type III secretion systems. Epidemiological data reveal a global distribution of enteric fever, with high incidence and mortality rates in Africa, Asia, and South America, while lower rates are reported in developed regions, often linked to international travel. This study adopts a One Health approach, examining Salmonella\u27s resistance, zoonotic transmission, and public health impact, while suggesting innovative strategies for detection and control to mitigate its global effects

    Estrus response and fertility rate in Kundhi buffaloes following estrus synchronization in breeding season

    No full text
    The aim of the present study was to compare the effect of two estrus synchronization treatments i.e., Ovsynch alone and Ovsynch plus Controlled Internal Drug Release (CIDR), on the occurrence of estrus and conception rate in Kundhi buffalo during breeding season in Pakistan. Forty Kundhi buffaloes were randomly selected and were divided into three groups; Group A (n=16; Ovsynch) received 2 mL GnRH intramuscularly (i/m) on day 0 and 9. On day 7, 5 mL prostaglandin F2 and #945; (PGF2 and #945; analogue) was administered through i/m route. The buffaloes of Group B (n=17; Ovsynch+CIDR) received 2 mL GnRH on day 0 along with implantation of CIDR. On day 7, the CIDR was removed, and 5 mL PGF2 and #945; analogue was injected through i/m route. A second dose of GnRH was administered through i/m route after 48 h of PGF2 and #945; inj. in both groups. Group C (n=7; control) received 2 mL normal saline through i/m route on day 0, 7 and 9. The buffaloes of all three groups were artificially inseminated twice (12 h and 24 h after the second GnRH inj.) using frozen-thawed semen. Estrus response differed significantly (P<0.05) among the groups. The animals of Group B (76.47%) showed superior estrus response as compared to others. Higher conception rate (52.94%) was observed in the animals of Group B; however, the difference was not significant. In conclusion, Ovsynch+CIDR causes to occur better estrus response and conception rate as compared to Ovsynch alone in Kundhi buffaloes during breeding season. [J Adv Vet Anim Res 2015; 2(3.000): 362-365

    Trypanosomiasis and its Diagnostic Techniques in Camel: a Comprehensive Review

    No full text
    Trypanosomiasis, a parasitic disease caused by protozoan parasites of the genus Trypanosoma, poses a significant threat to camel populations worldwide. This study designed for the diagnostic techniques used for detecting Trypanosoma infections specifically in camels. The disease, commonly known as camel trypanosomiasis or surra, adversely impacts the health and productivity of camels, thereby affecting livelihoods dependent on these animals. Various diagnostic methods are employed for the detection of Trypanosoma infection in camels, including microscopic examination of blood smears, serological tests like ELISA (Enzyme-Linked Immunosorbent Assay), and molecular techniques such as PCR (Polymerase Chain Reaction). Each method has its strengths and limitations in terms of sensitivity, specificity, and practicality in field settings. Efforts to control and manage camel trypanosomiasis rely heavily on accurate and timely diagnosis. Early detection facilitates prompt treatment and prevents the spread of the disease within camel herds. Additionally, the development and optimization of diagnostic tools tailored specifically for camels are crucial for effective disease surveillance and control. This study underscores the importance of ongoing research and innovation in diagnostic methodologies to combat trypanosomiasis in camel populations efficiently

    Biosynthesis of Selenium Nanoparticles (via Bacillus subtilis BSN313), and Their Isolation, Characterization, and Bioactivities

    No full text
    Among the trace elements, selenium (Se) has great demand as a health supplement. Compared to its other forms, selenium nanoparticles have minor toxicity, superior reactivity, and excellent bioavailability. The present study was conducted to produce selenium nanoparticles (SeNPs) via a biosynthetic approach using probiotic Bacillus subtilis BSN313 in an economical and easy manner. The BSN313 exhibited a gradual increase in Se reduction and production of SeNPs up to 5–200 µg/mL of its environmental Se. However, the capability was decreased beyond that concentration. The capacity for extracellular SeNP production was evidenced by the emergence of red color, then confirmed by a microscopic approach. Produced SeNPs were purified, freeze-dried, and subsequently characterized systematically using UV–Vis spectroscopy, FTIR, Zetasizer, SEM–EDS, and TEM techniques. SEM–EDS analysis proved the presence of selenium as the foremost constituent of SeNPs. With an average particle size of 530 nm, SeNPs were shown to have a −26.9 (mV) zeta potential and −2.11 µm cm/Vs electrophoretic mobility in water. SeNPs produced during both the 24 and 48 h incubation periods showed good antioxidant activity in terms of DPPH and ABST scavenging action at a concentration of 150 µg/mL with no significant differences (p &gt; 0.05). Moreover, 200 µg/mL of SeNPs showed antibacterial reactivity against Escherichia coli ATCC 8739, Staphylococcus aureus ATCC 9027, and Pseudomonas aeruginosa ATCC 25923. In the future, this work will be helpful to produce biogenic SeNPs using probiotic Bacillus subtilis BSN313 as biofactories, with the potential for safe use in biomedical and nutritional applications.</jats:p

    Biosynthesis of Selenium Nanoparticles (via Bacillus subtilis BSN313), and Their Isolation, Characterization, and Bioactivities

    No full text
    Among the trace elements, selenium (Se) has great demand as a health supplement. Compared to its other forms, selenium nanoparticles have minor toxicity, superior reactivity, and excellent bioavailability. The present study was conducted to produce selenium nanoparticles (SeNPs) via a biosynthetic approach using probiotic Bacillus subtilis BSN313 in an economical and easy manner. The BSN313 exhibited a gradual increase in Se reduction and production of SeNPs up to 5–200 µg/mL of its environmental Se. However, the capability was decreased beyond that concentration. The capacity for extracellular SeNP production was evidenced by the emergence of red color, then confirmed by a microscopic approach. Produced SeNPs were purified, freeze-dried, and subsequently characterized systematically using UV–Vis spectroscopy, FTIR, Zetasizer, SEM–EDS, and TEM techniques. SEM–EDS analysis proved the presence of selenium as the foremost constituent of SeNPs. With an average particle size of 530 nm, SeNPs were shown to have a −26.9 (mV) zeta potential and −2.11 µm cm/Vs electrophoretic mobility in water. SeNPs produced during both the 24 and 48 h incubation periods showed good antioxidant activity in terms of DPPH and ABST scavenging action at a concentration of 150 µg/mL with no significant differences (p &gt; 0.05). Moreover, 200 µg/mL of SeNPs showed antibacterial reactivity against Escherichia coli ATCC 8739, Staphylococcus aureus ATCC 9027, and Pseudomonas aeruginosa ATCC 25923. In the future, this work will be helpful to produce biogenic SeNPs using probiotic Bacillus subtilis BSN313 as biofactories, with the potential for safe use in biomedical and nutritional applications
    corecore